EUVIMEDEUVIMED entdecken
Crossref

8-Hydroxyquinoline derivatives suppress GLI1-mediated transcription through multiple mechanisms

Jiachen Wen, Radha Charan Dash, Angela M Zaino, Noah J Harrahill, Jackson T Calhoun, Christopher O Dusek, Shana R Morel, Matthew Russolillo, M Kyle Hadden

Bioorganic Chemistry · 2023

DOI: 10.1016/j.bioorg.2023.106387 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic Chemistry, 2023. Verfasst von Jiachen Wen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, University of Connecticut, 69 North Eagleville Rd, Unit 3092, Storrs, CT 06029-3092, United States. Hauptthemen laut MEDLINE: Transcription Factors, Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aberrant activation of the Hedgehog (Hh) signaling pathway has been observed in various human malignancies. Glioma-associated oncogene transcription factor 1 (GLI1) is the ultimate effector of the canonical Hh pathway and has also been identified as a common regulator of several tumorigenic pathways prevalent in Hh-independent cancers. The anti-cancer potential of GLI1 antagonism with small molecule inhibitors has demonstrated initial promise; however, the continued development of GLI1 inhibitors is still needed. We previously identified a scaffold containing an 8-hydroxyquinoline as a promising lead GLI1 inhibitor (compound 1). To further develop this scaffold, we performed a systematic structure-activity relationship study to map the structural requirements of GLI1 inhibition by this chemotype. A series of biophysical and cellular experiments identified compound 39 as an enhanced GLI1 inhibitor with improved activity. In addition, our studies on this scaffold suggest a potential role for SRC family kinases in regulating oncogenic GLI1 transcriptional activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcription FactorsNeoplasmsHumansZinc Finger Protein GLI1Hedgehog ProteinsSignal TransductionCell ProliferationCell Line, Tumor

Stichwörter der Autor:innen

8-HydroxyquinolineGLI1 inhibitorHedgehog pathwaySrc kinaseStructure-based drug design

Substanzen

Transcription FactorsZinc Finger Protein GLI1Hedgehog ProteinsGLI1 protein, human

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, University of Connecticut, 69 North Eagleville Rd, Unit 3092, Storrs, CT 06029-3092, United States.
  • Department of Pharmaceutical Sciences, University of Connecticut, 69 North Eagleville Rd, Unit 3092, Storrs, CT 06029-3092, United States. Electronic address: kyle.hadden@uconn.edu.

Zitieren

APA

Wen, J., Charan Dash, R., Zaino, A. M., Harrahill, N. J., Calhoun, J. T., Dusek, C. O., Morel, S. R., Russolillo, M., & Kyle Hadden, M. (2023). 8-Hydroxyquinoline derivatives suppress GLI1-mediated transcription through multiple mechanisms. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2023.106387

Vancouver

Wen J, Charan Dash R, Zaino AM, Harrahill NJ, Calhoun JT, Dusek CO, et al. 8-Hydroxyquinoline derivatives suppress GLI1-mediated transcription through multiple mechanisms. Bioorganic Chemistry. 2023. doi:10.1016/j.bioorg.2023.106387

BibTeX
@article{Wen2023,
  author = {Wen, Jiachen and Charan Dash, Radha and Zaino, Angela M and Harrahill, Noah J and Calhoun, Jackson T and Dusek, Christopher O and Morel, Shana R and Russolillo, Matthew and Kyle Hadden, M},
  title = {8-Hydroxyquinoline derivatives suppress GLI1-mediated transcription through multiple mechanisms},
  journal = {Bioorganic Chemistry},
  year = {2023},
  doi = {10.1016/j.bioorg.2023.106387}
}
Kostenlos starten →